SCHEMBL57874

SCHEMBL57874

O[C]1CCCCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3138187 1.00 TSHR (0.39)
SCHEMBL1379941 1.00
SCHEMBL3142403 1.00 TSHR (0.39)
SCHEMBL3144028 1.00 TSHR (0.39)
SCHEMBL3146489 1.00 TSHR (0.39)
SCHEMBL1378195 1.00
SCHEMBL5041884 0.96 TSHR (0.37)
SCHEMBL285689 0.95
SCHEMBL28397186 0.86
SCHEMBL127435 0.80

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 4677 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12042495-B2 MAP4K1 inhibitors BLUEPRINT MEDICINES CORPORATION (US) 2024-07-23 US claimed
CN-111406077-B Copolymers of halogenated olefins and halogenated comonomers 阿科玛股份有限公司 2024-07-05 CN claimed
EP-4385980-A1 INDAZOLES AS INHIBITORS OF NAV1.8 Grünenthal GmbH (DE) 2024-06-19 EP claimed
US-12012409-B2 Bicyclic heterocycles as FGFR inhibitors INCYTE CORPORATION (US) 2024-06-18 US claimed
CN-118184594-A Preparation method of aza-uracil compound, and compound prepared by same and application of aza-uracil compound 杭州医学院 2024-06-14 CN claimed
EP-4376819-A1 USE OF SGLT-2 INHIBITORS FOR THE PREVENTION AND/OR TREATMENT OF HYPERTENSION IN NON-HUMAN MAMMALS Boehringer Ingelheim Vetmedica GmbH (DE) 2024-06-05 EP claimed
EP-4376829-A1 USE OF SGLT-2 INHIBITORS FOR THE PREVENTION AND/OR TREATMENT OF CARDIAC DISEASES IN NON-HUMAN MAMMALS EXCLUDING FELINES, IN PARTICULAR CANINES Boehringer Ingelheim Vetmedica GmbH (DE) 2024-06-05 EP claimed
EP-4376830-A1 USE OF SGLT-2 INHIBITORS FOR THE PREVENTION AND/OR TREATMENT OF RENAL DISEASES IN NON-HUMAN MAMMALS Boehringer Ingelheim Vetmedica GmbH (DE) 2024-06-05 EP claimed
EP-4373895-A1 UV CURABLE THERMOFORMABLE CONDUCTIVE INK AND DIELECTRIC INK Sun Chemical Corporation (US) 2024-05-29 EP claimed
CN-118019736-A Molecular gel compound designed based on cereblon protein and application thereof 标新生物医药科技(上海)有限公司 2024-05-10 CN claimed
EP-0138754-A2 Photocurable compositions CIBA-GEIGY AG (CH) 1985-04-24 EP claimed
EP-0117233-A1 Coloured photo-curable mouldings CIBA-GEIGY AG (CH) 1984-08-29 EP claimed
EP-0088050-A2 Coloured photo-hardenable composition CIBA-GEIGY AG (CH) 1983-09-07 EP claimed
EP-0055444-A2 Trisubstituted pyrimido(5,4-d)pyrimidines, their preparation and medicaments containing them Dr. Karl Thomae GmbH (DE) 1982-07-07 EP claimed
US-4180655-A ANTITUMOR AND ANTILEUKEMIA AGENTS Suami, Tetsuo (JP) 1979-12-25 US claimed
US-4113777-A ANTISECRETORY, ANTITUSSIVE, ANTIULCER BOEHRINGER INGELHEIM GMBH (DE) 1978-09-12 US claimed
US-4073942-A Halo-substituted hydroxybenzyl-amines as secretolytic agents BOEHRINGER INGELHEIM GMBH (DT) 1978-02-14 US claimed
US-3998802-A POLYAMIDES, CELLULOSE ESTERS, POLYESTERS, POLYACRYLONITRILES BASF AKTIENGESELLSCHAFT (DT) 1976-12-21 US claimed
US-3980677-A Anthraquinone dyestuffs containing sulphonic acid groups BAYER AKTIENGESELLSCHAFT (DT) 1976-09-14 US claimed
US-3979413-A Polycyclic dyestuffs BAYER AKTIENGESELLSCHAFT (DT) 1976-09-07 US claimed